Interestingly, in our context, the scaffolding SP2509 inhibitor treatment led immature LOUCY ETP-ALL cells to increase expression of CD3ε a mature T cell marker (Fig. 6C). The gene discussed is CD3E; the disease is acute lymphoblastic leukemia.